Shanghai-based 111 In., which runs an online retail drugstore and healthcare platform in China, has filed for U.S. initial public offering to raise US$200 million under the name YI, according to its prospectus. J.P. Morgan, Citi and CICC are the joint bookrunners of the deal, but the pricing terms were undisclosed. Founded in 2010, 111 Inc’s main business lines include 1 Drugstore – an online B2C pharmacy platform, 1 Clinic – a digital-first hospital, and 1 Drug Mall – an …

Chinese Online Drugstore 111 Inc. Files For $200M US IPO appeared first on China Money Network.